Impact of HAT 2 CH 2 Score on the Development of No-Reflow Phenomenon in Patients With ST-Segment Elevation Myocardial Infarction.
Hazar HarbalioğluÖmer GençGökhan AlıcıAlaa QuisiAbdullah YıldırımPublished in: Angiology (2023)
The HAT 2 CH 2 score [Hypertension (1 point), Age > 75 years (1 point), Stroke/Transient ischemic attack (2 points), Chronic obstructive pulmonary disease (1 point), and Heart failure (2 points)] was originally developed to predict the occurrence of new-onset atrial fibrillation. The aim of the present study was to examine whether this score could predict the development of no-reflow phenomenon (NR) in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI). Patients (n = 1552) with STEMI were consecutively enrolled in this single-center retrospective study. The SYNTAX score (SXscore) and HAT 2 CH 2 score were calculated. The presence of thrombolysis in myocardial infarction (TIMI) score ≤2, without significant residual stenosis and mechanical obstruction, indicated the presence of NR. The HAT 2 CH 2 score was significantly higher in the NR (+) group compared with the NR (-) group [2.29 ± 1.43 vs 1.46 ± 1.24, p < .001]. In multivariable logistic regression analysis, the HAT 2 CH 2 score [OR = 1.585, p < .001] and SXscore [OR = 1.028, p = .017] were found to be independent predictors of NR. Receiver operating characteristic curve analysis showed that the HAT 2 CH 2 score with a cutoff value of >2 determined NR, with 50.2% sensitivity and 79.4% specificity (AUC = .669, p < .001). In conclusion, the HAT 2 CH 2 score may facilitate risk stratification in estimating NR in STEMI patients undergoing pPCI.
Keyphrases
- st segment elevation myocardial infarction
- percutaneous coronary intervention
- atrial fibrillation
- heart failure
- st elevation myocardial infarction
- patients undergoing
- acute coronary syndrome
- coronary artery disease
- room temperature
- antiplatelet therapy
- chronic obstructive pulmonary disease
- end stage renal disease
- coronary artery bypass grafting
- pulmonary embolism
- blood pressure
- chronic kidney disease
- peritoneal dialysis
- left ventricular
- left atrial appendage
- coronary artery bypass
- direct oral anticoagulants
- air pollution
- catheter ablation